Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Congenital Heart Disease|September 6, 2018
Coronary artery intimal thickening and ventricular dynamics in pediatric heart transplant recipientsAnita T Cote, Martin Hosking, Christine Voss, et al.Frontiers in Pediatrics|March 17, 2023
A Canadian, retrospective, multicenter experience with selexipag for a heterogeneous group of pediatric pulmonary hypertension patientsDavid Youssef, Susan Richards, Sabine Lague, et al.Translational Pediatrics|March 9, 2023
Targeted neonatal echocardiography for patent ductus arteriosus in neonates reduces the surgical ligation rate without affecting healthcare outcomesKrishan Yadav, Audrey Hebert, Karen Lavie-Nevo, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|November 7, 2023
The impact of a care bundle with an emphasis on hemodynamic assessment on the short-term outcomes in neonates with congenital diaphragmatic herniaMimi T Y Kuan, Krishan Yadav, Michael Castaldo, et al.Pediatric Blood & Cancer|January 30, 2014
VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in childrenKaitlyn Shaw, Ursula Amstutz, Claudette Hildebrand, et al.Journal for Immunotherapy of Cancer|December 6, 2023
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targetingKristin M Snyder, Kate J Dixon, Zachary Davis, et al.Frontiers in Immunology|August 5, 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphomaKate J Dixon, Kristin M Snyder, Melissa Khaw, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2025
A novel CD3ε fusion receptor allows T cell engager use in TCR-less allogeneic CAR T cells to improve activity and prevent antigen escapeDan Lu, Hui-Yi Chu, Soo Park, et al.Cell Reports. Medicine|June 20, 2025
iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumorsBi-Huei Yang, Alma Gutierrez, Angela Liao, et al.Pageof 2